FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2009457856> ?p ?o ?g. }

• W2009457856 endingPage "551" @default.
• W2009457856 startingPage "544" @default.
• W2009457856 abstract "Background: To investigate the relationship between the expression of glucose-regulated protein94 (GRP94) and GRP78 at the level of mRNA and protein in vivo and in human lung cancer. Methods: RT-PCR, real-time PCR, immunohistochemistry and/or Western blot were used in 54 cases of lung cancer and corresponding normal lung tissue. Results: The expression pattern of GRP94 and GRP78 was similar. There was a significant overexpression of GRP94 and GRP78 at both mRNA and protein levels in cancer tissues as compared to normal tissues. The relative levels of GRP94 and GRP78 mRNA evaluated by RT-PCR in cancer and normal lung tissue were: GRP94: 3.48 ± 2.06 versus 2.01 ± 1.83; GRP78: 3.64 ± 1.87 versus 2.21 ± 1.54; by real-time PCR were: GRP94: 2.89 ± 0.64 versus 1.12 ± 0.54; GRP78: 2.56 ± 0.82 versus 0.96 ± 0.42. The relative level of GRP94 and GRP78 protein by Western blot in cancer and normal lung tissue were: GRP94: 3.46 ± 1.72 versus 1.81 ± 0.92; GRP78: 4.84 ± 2.55 versus 1.91 ± 1.15, indicating an approximate 2-fold and a 3-fold increase in GRP94 and GRP78 protein in cancer tissue as compared with normal tissue. Immunohistochemistry result for GRP94 and GRP78 in cancer and normal tissue was similar, that is: a stronger stain was observed in cancer tissue (main intensity of staining ++ to +++) compared to normal tissue (main intensity of staining + to ++). All the difference for GRP94 and GRP78 between the two tissues were significant (p < 0.05). Furthermore, the overexpression of GRP94 and GRP78 in the cancer tissue correlated with grade of differentiation and stage of tumors. There was stronger expression in poorly differentiated tumors than in well-moderately differentiated tumors (p < 0.05). There was also stronger expression in stage III than in stages I and II tumors (p < 0.05). No statistically significant differences were found among various pathologic types of tumors. Correlation analysis showed that there is a positive correlation between GRP94 and GRP78. Conclusion: The expression pattern of GRP94 and GRP78 was similar in human lung cancer. They both were related with the differentiation and progression of the cancer. The expression at mRNA and protein level may be valuable in evaluating the grade of differentiation and clinical stage of human lung cancer." @default.
• W2009457856 created "2016-06-24" @default.
• W2009457856 creator A5015195367 @default.
• W2009457856 creator A5016226574 @default.
• W2009457856 creator A5019076324 @default.
• W2009457856 creator A5025843427 @default.
• W2009457856 creator A5030305487 @default.
• W2009457856 creator A5042151372 @default.
• W2009457856 creator A5047331900 @default.
• W2009457856 creator A5049183495 @default.
• W2009457856 creator A5062121176 @default.
• W2009457856 date "2005-01-01" @default.
• W2009457856 modified "2023-10-02" @default.
• W2009457856 title "Overexpression of endoplasmic reticulum molecular chaperone GRP94 and GRP78 in human lung cancer tissues and its significance" @default.
• W2009457856 cites W1479809193 @default.
• W2009457856 cites W1495548641 @default.
• W2009457856 cites W1569077405 @default.
• W2009457856 cites W1965261736 @default.
• W2009457856 cites W1969809609 @default.
• W2009457856 cites W1981170034 @default.
• W2009457856 cites W1997451852 @default.
• W2009457856 cites W1997500225 @default.
• W2009457856 cites W2001609208 @default.
• W2009457856 cites W2002725367 @default.
• W2009457856 cites W2008765353 @default.
• W2009457856 cites W2011958996 @default.
• W2009457856 cites W2020437934 @default.
• W2009457856 cites W2030033908 @default.
• W2009457856 cites W2035826838 @default.
• W2009457856 cites W2051793369 @default.
• W2009457856 cites W2053823780 @default.
• W2009457856 cites W2062448590 @default.
• W2009457856 cites W2065989978 @default.
• W2009457856 cites W2068868177 @default.
• W2009457856 cites W2072861830 @default.
• W2009457856 cites W2077041565 @default.
• W2009457856 cites W2082760627 @default.
• W2009457856 cites W2084068959 @default.
• W2009457856 cites W2152398979 @default.
• W2009457856 cites W2157838103 @default.
• W2009457856 doi "https://doi.org/10.1016/j.cdp.2005.09.010" @default.
• W2009457856 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/16297569" @default.
• W2009457856 hasPublicationYear "2005" @default.
• W2009457856 type Work @default.
• W2009457856 sameAs 2009457856 @default.
• W2009457856 citedByCount "122" @default.
• W2009457856 countsByYear W20094578562012 @default.
• W2009457856 countsByYear W20094578562013 @default.
• W2009457856 countsByYear W20094578562014 @default.
• W2009457856 countsByYear W20094578562015 @default.
• W2009457856 countsByYear W20094578562016 @default.
• W2009457856 countsByYear W20094578562017 @default.
• W2009457856 countsByYear W20094578562018 @default.
• W2009457856 countsByYear W20094578562019 @default.
• W2009457856 countsByYear W20094578562020 @default.
• W2009457856 countsByYear W20094578562021 @default.
• W2009457856 countsByYear W20094578562022 @default.
• W2009457856 countsByYear W20094578562023 @default.
• W2009457856 crossrefType "journal-article" @default.
• W2009457856 hasAuthorship W2009457856A5015195367 @default.
• W2009457856 hasAuthorship W2009457856A5016226574 @default.
• W2009457856 hasAuthorship W2009457856A5019076324 @default.
• W2009457856 hasAuthorship W2009457856A5025843427 @default.
• W2009457856 hasAuthorship W2009457856A5030305487 @default.
• W2009457856 hasAuthorship W2009457856A5042151372 @default.
• W2009457856 hasAuthorship W2009457856A5047331900 @default.
• W2009457856 hasAuthorship W2009457856A5049183495 @default.
• W2009457856 hasAuthorship W2009457856A5062121176 @default.
• W2009457856 hasConcept C104317684 @default.
• W2009457856 hasConcept C105580179 @default.
• W2009457856 hasConcept C121608353 @default.
• W2009457856 hasConcept C139447449 @default.
• W2009457856 hasConcept C142724271 @default.
• W2009457856 hasConcept C153911025 @default.
• W2009457856 hasConcept C158617107 @default.
• W2009457856 hasConcept C204232928 @default.
• W2009457856 hasConcept C2776256026 @default.
• W2009457856 hasConcept C2776415932 @default.
• W2009457856 hasConcept C2780995651 @default.
• W2009457856 hasConcept C54355233 @default.
• W2009457856 hasConcept C55493867 @default.
• W2009457856 hasConcept C71924100 @default.
• W2009457856 hasConcept C74864618 @default.
• W2009457856 hasConcept C86803240 @default.
• W2009457856 hasConcept C96232424 @default.
• W2009457856 hasConceptScore W2009457856C104317684 @default.
• W2009457856 hasConceptScore W2009457856C105580179 @default.
• W2009457856 hasConceptScore W2009457856C121608353 @default.
• W2009457856 hasConceptScore W2009457856C139447449 @default.
• W2009457856 hasConceptScore W2009457856C142724271 @default.
• W2009457856 hasConceptScore W2009457856C153911025 @default.
• W2009457856 hasConceptScore W2009457856C158617107 @default.
• W2009457856 hasConceptScore W2009457856C204232928 @default.
• W2009457856 hasConceptScore W2009457856C2776256026 @default.
• W2009457856 hasConceptScore W2009457856C2776415932 @default.
• W2009457856 hasConceptScore W2009457856C2780995651 @default.
• W2009457856 hasConceptScore W2009457856C54355233 @default.
• W2009457856 hasConceptScore W2009457856C55493867 @default.

• next